Massel D, Cruickshank M K
Division of Cardiology, Department of Medicine, University of Western Ontario, London.
Can J Cardiol. 2002 Mar;18(3):254-8.
Although the number of patients needed to treat (NNT) to prevent an adverse clinical event is of great clinical value to practising physicians, it is limited in that it fails to provide a measure of prognosis among patients not achieving benefit. For example, if the NNT is 100, what is likely to happen to the other 99? The number remaining at risk (NRR), which is an index that enhances the value of the NNT, is described. The NRR is the ratio of the residual event rate among treated patients and the absolute reduction in outcome events (NRR = experimental event rate [EER]/control event rate [CER]-EER), where EER and CER are the event rates among experimental and control groups, respectively. This index represents the number of events likely to occur among the NNT, or the odds of experiencing an adverse outcome event as opposed to deriving benefit from therapy. The NRR is a simple index that can easily be calculated from the published results of a clinical trial. As an adjunct to the NNT, it provides a measure of the impact of therapy and the average prognosis of remaining patients.
虽然预防不良临床事件所需治疗的患者数量(NNT)对执业医师具有重大临床价值,但它存在局限性,即未能提供未获益处患者的预后衡量指标。例如,如果NNT为100,那么另外99人可能会怎样?本文介绍了风险留存率(NRR),这是一个提升NNT价值的指标。NRR是治疗患者中残余事件发生率与结局事件绝对降低率之比(NRR = 试验组事件发生率[EER]/对照组事件发生率[CER] - EER),其中EER和CER分别是试验组和对照组的事件发生率。该指标代表了NNT中可能发生的事件数量,即经历不良结局事件而非从治疗中获益的几率。NRR是一个简单的指标,可根据临床试验已发表的结果轻松计算得出。作为NNT的补充,它提供了治疗影响及剩余患者平均预后的衡量指标。